| 16.05 0.56 (3.62%) | 04-23 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 20.85 | 1-year : | 22.79 |
| Resists | First : | 17.85 | Second : | 19.52 |
| Pivot price | 16.28  |
|||
| Supports | First : | 15.15 | Second : | 12.61 |
| MAs | MA(5) : | 15.59 |
MA(20) : | 16.44 |
| MA(100) : | 16.62 |
MA(250) : | 12.81 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 16.8 |
D(3) : | 11.2 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 20.9 | Low : | 6.51 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZIMV ] has closed above bottom band by 41.5%. Bollinger Bands are 29.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 16.12 - 16.19 | 16.19 - 16.25 |
| Low: | 15.35 - 15.42 | 15.42 - 15.49 |
| Close: | 15.93 - 16.05 | 16.05 - 16.16 |
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Sat, 13 Apr 2024
ZimVie Inc. (NASDAQ:ZIMV) Sees Significant Increase in Short Interest - MarketBeat
Mon, 01 Apr 2024
ZimVie Inc Finalizes Strategic Spine Business Sale for $375M - TipRanks.com - TipRanks
Mon, 01 Apr 2024
ZimVie closes spine business sale - Mass Device
Mon, 25 Mar 2024
ZIMV Stock Quote Price and Forecast - CNN
Fri, 15 Mar 2024
Multiple Reasons for the Surge of ZimVie (ZIMV) in Q4 - Yahoo Finance
Wed, 28 Feb 2024
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results - OrthoSpineNews
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 27 (M) |
| Shares Float | 21 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 98.6 (%) |
| Shares Short | 788 (K) |
| Shares Short P.Month | 564 (K) |
| EPS | -2.12 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 15.11 |
| Profit Margin | -86 % |
| Operating Margin | -4.9 % |
| Return on Assets (ttm) | -0.5 % |
| Return on Equity (ttm) | -9.7 % |
| Qtrly Rev. Growth | -50.8 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 16.8 |
| EBITDA (p.s.) | 0.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 37 (M) |
| Levered Free Cash Flow | 49 (M) |
| PE Ratio | -7.58 |
| PEG Ratio | -6.9 |
| Price to Book value | 1.06 |
| Price to Sales | 0.95 |
| Price to Cash Flow | 11.75 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|